Back to Market Feed

Product Information

PREGABALIN 225 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.0562 per EA under NDC 69097068405. Its NADAC has been published 303 times since Nov 4, 2020.

FDA first approved this application on Jan 10, 2020.

PREGABALIN 225 MG CAPSULE

PREGABALIN capsules, CV
$0.0562per EA
DEA Schedule CV

Strength

225 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097068405

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA212280

FDA Approved

1/10/2020

On Market Since

1/10/2020

Price Statistics

The NADAC for PREGABALIN 225 MG CAPSULE has been published 303 times since Nov 4, 2020, and over the history we have for it it has declined 60.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0562 per EA
All-time high$0.1559 (Dec 16, 2020)
All-time low$0.0529 (Nov 20, 2024)
52-week high$0.0702
52-week low$0.0543
Median price$0.0857
Average price$0.0893
Largest weekly change-29.0% (Nov 20, 2024)
Weeks tracked303
Tracking sinceNov 4, 2020

Price History

1W

+3.5%

1M

+3.5%

3M

+1.1%

6M

-7.6%

1Y

-19.9%

3Y

-34.7%

5Y

-55.5%

All

-60.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PREGABALIN capsules, CV market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of PREGABALIN 225 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 225 MG CAPSULE, manufactured by Cipla USA Inc., is $0.0562 per EA (NDC 69097068405), effective Aug 19, 2026.

How has the price of PREGABALIN 225 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 225 MG CAPSULE has declined 60.4%. It has been tracked across 303 weekly CMS publications since Nov 4, 2020.

What are the highest and lowest recorded NADAC prices for PREGABALIN 225 MG CAPSULE?

Since Nov 4, 2020, the NADAC for PREGABALIN 225 MG CAPSULE has ranged from a low of $0.0529 (Nov 20, 2024) to a high of $0.1559 (Dec 16, 2020), with a median of $0.0857 per EA.

Are there cheaper alternatives to PREGABALIN 225 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of PREGABALIN 225 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PREGABALIN 225 MG CAPSULE?

PREGABALIN 225 MG CAPSULE (NDC 69097068405) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.